BetterScholar BetterScholar

P. Walther

Journal of Urology, Cancer, Journal of the American Medical Association, Journal of the National Cancer Institute, The Journal of the National Comprehensive Cancer Network, Urology, Oncogene, Cancer Epidemiology, Biomarkers and Prevention Show more
12
Role
Title
Level Year L/R
🐜 Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
34 auth. S. Lippman, E. Klein, E. Klein, P. Goodman, M. Lucia, I. Thompson, L. Ford, H. Parnes, L. Minasian, J. M. Gaziano, J. Hartline, J. Parsons, J. Bearden, E. Crawford, G. Goodman, ... Jaime Claudio, E. Winquist, E. Cook, D. Karp, P. Walther, M. Lieber, A. Kristal, A. Darke, Kathryn B. Arnold, P. Ganz, R. Santella, D. Albanes, P. Taylor, J. Probstfield, T. Jagpal, J. Crowley, F. Meyskens, L. Baker, C. Coltman 		11 2009
11
🐜
🐜 Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT )
21 auth. E. Klein, I. Thompson, C. Tangen, J. Crowley, M. S. Lucia, P. Goodman, L. Minasian, L. Ford, H. Parnes, J. M. Gaziano, ... D. Karp, M. Lieber, P. Walther, L. Klotz, J. Parsons, J. Chin, A. Darke, S. Lippman, G. Goodman, F. Meyskens, L. Baker 		9 2011
9
🐜
🐜 Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
26 auth. S. Lippman, P. Goodman, E. Klein, H. Parnes, I. Thompson, A. Kristal, R. Santella, J. Probstfield, C. Moinpour, D. Albanes, P. Taylor, L. Minasian, A. Hoque, Sarah M. Thomas, J. J. Crowley, ... J. M. Gaziano, J. Stanford, E. Cook, N. Fleshner, M. Lieber, P. Walther, F. Khuri, D. Karp, G. Schwartz, L. Ford, C. Coltman 		8 2005
8
🐜
🐜 Bladder cancer. Clinical practice guidelines in oncology.
19 auth. J. Montie, R. Bahnson, S. Cohen, B. Drucker, M. Eisenberger, R. El-Galley, H. Herr, G. Hudes, T. Kuzel, P. Lange, ... A. Patterson, A. Pollack, J. Richie, J. Seigne, W. Shipley, E. Small, D. Trump, P. Walther, T. Wilson 		8 2005
8
🐜
🐜 Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma
10 auth. T. M. Law, R. Motzer, M. Mazumdar, K. Sell, P. Walther, M. O’connell, ... A. Khan, V. Vlamis, N. Vogelzang, D. Bajorin 		8 1995
8
🐜
🐜 Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.
9 auth. W. Demark-Wahnefried, D. Price, T. Polascik, C. Robertson, E. Anderson, D. Paulson, ... P. Walther, Melissa Gannon, R. Vollmer 		7 2001
7
🐜
🐬 Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer
R. Carstens, James V Eaton, H. Krigman, P. Walther, M. Garcia-Blanco 		7 1997
7
🐬
🐜 Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery
18 auth. W. Demark-Wahnefried, T. Polascik, S. George, B. Switzer, J. Madden, M. Ruffin, Denise C. Snyder, K. Owzar, V. Hárs, D. Albala, ... P. Walther, C. Robertson, J. Moul, B. Dunn, D. Brenner, L. Minasian, P. Stella, R. Vollmer 		7 2008
7
🐜
🐢 Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
8 auth. S. E. Lee, S. E. Lee, Samuel M. Currin, Samuel M. Currin, D. Paulson, D. Paulson, ... P. Walther, P. Walther 		6 1988
6
🐢
🐢 Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
8 auth. S. E. Lee, S. E. Lee, Samuel M. Currin, Samuel M. Currin, D. Paulson, D. Paulson, ... P. Walther, P. Walther 		6 1988
6
🐢
🐜 Salvage radiation in men after prostate‐specific antigen failure and the risk of death
10 auth. Shane E. Cotter, Ming H. Chen, J. Moul, W. Lee, B. Koontz, M. Anscher, ... C. Robertson, P. Walther, T. Polascik, A. D'Amico 		6 2011
6
🐜
🐜 Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
11 auth. Leon L Sun, A. Caire, C. Robertson, D. George, T. Polascik, K. Maloney, ... P. Walther, D. Stackhouse, B. Lack, D. Albala, J. Moul 		6 2009
6
🐜